The Clorox Company (NYSE:CLX) saw a downside of -0.59% to $162.77 after subtracting -$0.97 on Tuesday. The 5-day average trading volume is 1,980,100 shares of the company’s common stock. It has gained $169.14 in the past week and touched a new high 2 times within the past 5 days. An average of 1,383,595 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,197,890.
CLX’s 1-month performance is 4.04% or $4.57 on its low of $149.73 reached on 07/20/23. The company’s shares have touched a 52-week low of $124.58 and high of $178.21, with the stock’s rally to the 52-week high happening on 05/03/23. YTD, CLX has achieved 15.99% or $22.24 and has reached a new high 17 times. However, the current price is down -8.66% from the 52-week high price.
Valuation Metrics
CLX stock has a beta of 0.25. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 2.76 while the price-to-book (PB) in the most recent quarter is 8138.50, with the price to cash flow ratio at 141.54.
The Clorox Company’s quick ratio for the period ended June 29 was 0.50, with the current ratio over the same period at 0.90. As well, the company’s long term debt to equity for the quarter ending June 29 was 825.33, while the total debt to equity was 871.33. In terms of profitability, the gross margin trailing 12 months is 39.30%. The firm’s gross profit as reported stood at $2.54 billion against revenue of $7.11 billion.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 171.09% to -$211.0 million, while revenue of $99.0 million was 146.92% off the previous quarter. Analysts expected CLX to announce $1.18 per share in earnings in its latest quarter, but it posted $1.67, representing a 41.50% surprise. EBITDA for the quarter stood at more than $308.0 million. CLX stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 5.65 billion, with total debt at $2.92 billion. Shareholders hold equity totaling $123.62 million.
Let’s look briefly at The Clorox Company (CLX) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 07 August was 63.85% to suggest the stock is trending Neutral, with historical volatility in this time period at 47.79%.
The stock’s 5-day moving average is $161.78, reflecting a +7.15% or $10.85 change from its current price. CLX is currently trading +4.98% above its 20-day SMA, +3.98% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +2.67% and SMA200 by+18.77%.
Stochastic %K and %D was 70.63% and 71.48% and the average true range (ATR) pointed at 3.79. The RSI (14) points at 60.56%, while the 14-day stochastic is at 66.13% with the period’s ATR at 3.45. The stock’s 9-day MACD Oscillator is pointing at 6.01 and 7.08 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for The Clorox Company (NYSE: CLX), Atlantic Equities upgraded it to a Neutral rating. They previously had an Underweight rating on the stock. Analysts offering their rating for CLX stock have a consensus rating for the stock as Underweight. Currently, 6 brokerage advisors rate CLX as a “sell,”, while 9 advise that investors “Hold.” 3 analysts have rated the stock as underweight. 1 rates the stock as overweight while 1 have offered a “buy” rating.
What is CLX’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $127.00 and a high of $185.00, with their median price target at $157.00. Looking at these predictions, the average price target given by analysts is for The Clorox Company (CLX) stock is $158.53.
